Glycogen synthase kinase 3 controls migration of the neural crest lineage in mouse and Xenopus.

scientific article published on 19 March 2018

Glycogen synthase kinase 3 controls migration of the neural crest lineage in mouse and Xenopus. is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2018NatCo...9.1126G
P6179Dimensions Publication ID1101559592
P356DOI10.1038/S41467-018-03512-5
P932PMC publication ID5859133
P698PubMed publication ID29555900

P50authorMatthias KrauseQ44831846
Louis CheslerQ58398809
Hadeel Adel Al-LamiQ59544103
Evon PoonQ63376603
Sandra Guadalupe Gonzalez MalagonQ90844413
Karen J. LiuQ41841535
P2093author name stringChristopher J Phiel
Anna M Lopez Muñoz
Daniel Doro
Elizabeth R Tucker
Triòna G Bolger
P2860cites workImmunoaffinity profiling of tyrosine phosphorylation in cancer cellsQ21735929
Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysisQ24529125
GSK-3: tricks of the trade for a multi-tasking kinaseQ24624069
Identification of ALK as a major familial neuroblastoma predisposition geneQ24655923
GSK-3-selective inhibitors derived from Tyrian purple indirubinsQ27642879
Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6Q27682291
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphomaQ27851421
Activating mutations in ALK provide a therapeutic target in neuroblastomaQ27851452
Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis.Q27853323
Inhibition of GSK-3beta leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithiumQ28269508
Lamellipodin, an Ena/VASP ligand, is implicated in the regulation of lamellipodial dynamicsQ28286512
Novel reporter alleles of GSK-3α and GSK-3βQ28485292
Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarityQ28568803
The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3Q29614380
Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinaseQ29615040
Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouseQ29620355
Lamellipodin and the Scar/WAVE complex cooperate to promote cell migration in vivoQ30557898
Neural crest induction by Xwnt7B in XenopusQ42672853
Interactions between Twist and other core epithelial-mesenchymal transition factors are controlled by GSK3-mediated phosphorylation.Q42755971
Glycogen synthase kinase 3beta is tyrosine phosphorylated by PYK2.Q43631715
Enteric nervous system progenitors are coordinately controlled by the G protein-coupled receptor EDNRB and the receptor tyrosine kinase RET.Q44682327
Inactivation of Cdc42 in neural crest cells causes craniofacial and cardiovascular morphogenesis defectsQ44928146
The MAP kinase pathway is upstream of the activation of GSK3beta that enables it to phosphorylate MAP1B and contributes to the stimulation of axon growth.Q45287460
Ectodermal Wnt function as a neural crest inducer.Q46043546
Characterization of the expression of the ALK receptor tyrosine kinase in miceQ46927486
Temporal control of neural crest lineage generation by Wnt/β-catenin signaling.Q51785160
Chemical rescue of cleft palate and midline defects in conditional GSK-3beta mice.Q51994753
Overexpression of Xgsk-3 disrupts anterior ectodermal patterning in Xenopus.Q52201903
Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation.Q54633263
Regulation of Spemann organizer formation by the intracellular kinase Xgsk-3Q72164616
Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extractsQ73958600
In silico studies of potential phosphoresidues in the human nucleophosmin/B23: its kinases and related biological processesQ84099764
Rac1 nucleocytoplasmic shuttling drives nuclear shape changes and tumor invasionQ86636596
GSK3 and Polo-like kinase regulate ADAM13 function during cranial neural crest cell migrationQ30607535
Regulation of dorsal fate in the neuraxis by Wnt-1 and Wnt-3aQ33721756
Neural crest cell-specific deletion of Rac1 results in defective cell-matrix interactions and severe craniofacial and cardiovascular malformationsQ33788024
Dissection of Xenopus laevis neural crest for in vitro explant culture or in vivo transplantationQ34009403
Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivoQ34179931
GSK3 takes centre stage more than 20 years after its discoveryQ34374129
NEURODEVELOPMENT. Shared regulatory programs suggest retention of blastula-stage potential in neural crest cellsQ34474556
An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanismsQ34625881
Contact inhibition of locomotion in vivo controls neural crest directional migrationQ34902880
What Are the bona fide GSK3 Substrates?Q35001234
Polarized regulation of glycogen synthase kinase-3β is important for glioma cell invasionQ35061356
Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK.Q35575978
The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastomaQ36160258
Small molecules targeting glycogen synthase kinase 3 as potential drug candidates for the treatment of retinitis pigmentosa.Q36257802
A stable cranial neural crest cell line from mouseQ36390173
Delamination of neural crest cells requires transient and reversible Wnt inhibition mediated by Dact1/2Q37036244
Glycogen synthase kinase 3 in the world of cell migrationQ37627916
Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivoQ37718461
The connections between neural crest development and neuroblastomaQ37836006
Rho family GTPasesQ38061989
New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK.Q38130615
Glycogen synthase kinase-3beta phosphorylation of MAP1B at Ser1260 and Thr1265 is spatially restricted to growing axons.Q38330149
Tackling Crizotinib Resistance: The Pathway from Drug Discovery to the Pediatric ClinicQ38540135
GSK3 inhibitors in the therapeutic development of diabetes, cancer and Neurodegeneration: Past, present and futureQ38656644
MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cellsQ39367969
Primary culture of chick, mouse or human neural crest cellsQ39465676
Regulation of FAK Ser-722 phosphorylation and kinase activity by GSK3 and PP1 during cell spreading and migrationQ39498392
Controlled levels of canonical Wnt signaling are required for neural crest migrationQ39657006
Oncogenic mutations of ALK kinase in neuroblastomaQ39928776
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastomaQ39928780
FAK phosphorylation at Ser-843 inhibits Tyr-397 phosphorylation, cell spreading and migration.Q40209895
Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylationQ40872093
MYCN induces neuroblastoma in primary neural crest cells.Q41599713
Cytogenetic and molecular characterization of a newly established neuroblastoma cell line LS.Q41688422
An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling.Q41810461
Reprogramming of avian neural crest axial identity and cell fateQ42372116
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P4510describes a project that usesImageJQ1659584
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)1126
P577publication date2018-03-19
P1433published inNature CommunicationsQ573880
P1476titleGlycogen synthase kinase 3 controls migration of the neural crest lineage in mouse and Xenopus.
P478volume9

Reverse relations

cites work (P2860)
Q549776959-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma.
Q58786649ALK and GSK3: Shared Features of Neuroblastoma and Neural Crest Cells
Q64117777BMP4 and Neuregulin regulate the direction of mouse neural crest cell differentiation
Q91891632Integrating chemical and mechanical signals in neural crest cell migration
Q95293828Modulation of β-catenin levels regulates cranial neural crest patterning and dispersal into first pharyngeal arch
Q58585886Rosmarinic Acid Derivatives' Inhibition of Glycogen Synthase Kinase-3β Is the Pharmacological Basis of Kangen-Karyu in Alzheimer's Disease
Q91811171The Many Faces of Xenopus: Xenopus laevis as a Model System to Study Wolf-Hirschhorn Syndrome

Search more.